SEC Form 4 · accession 0001209191-19-015649
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kory James Wentworth
Officer — Principal Accounting Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | S | 51 | $151.71 | D | 6,695 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported as sold herein were originally acquired under the bluebird bio, Inc. employee stock purchase plan on January 31, 2019.